5 years of historical data (2020–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Syra Health Corp. Class A Common Stock currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $60000 | $3M | $5M | — | — | — |
| Enterprise Value | $-1883328 | $1M | $2M | — | — | — |
| P/E Ratio → | -0.19 | — | — | — | — | — |
| P/S Ratio | 0.01 | 0.37 | 0.90 | — | — | — |
| P/B Ratio | 0.25 | 1.04 | 1.23 | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.13 | 0.35 | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Syra Health Corp. Class A Common Stock earns an operating margin of -47.2%. Operating margins have compressed from -37.2% to -47.2% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -109.1% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 20.7% | 20.7% | 25.5% | 18.9% | 30.5% | — |
| Operating Margin | -47.2% | -47.2% | -52.4% | -37.2% | -0.2% | — |
| Net Profit Margin | -47.1% | -47.1% | -53.3% | -37.7% | -0.2% | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -109.1% | -109.1% | -124.4% | -602.6% | — | — |
| ROA | -87.4% | -87.4% | -81.1% | -148.3% | -1.2% | -142.2% |
| ROIC | -294.7% | -294.7% | -165.1% | -167.0% | -2.1% | — |
| ROCE | -106.4% | -106.4% | -120.7% | -487.2% | -8.2% | — |
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $2M exceeds total debt of $452077, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | 0.16 | 0.16 | 0.06 | 1.32 | — | — |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.68 | -0.76 | 1.31 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -241.34 | -241.34 | -53.79 | -73.24 | — | — |
Net cash position: cash ($2M) exceeds total debt ($452077)
Short-term solvency ratios and asset-utilisation metrics
Syra Health Corp. Class A Common Stock's current ratio of 5.46x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.92x to 5.46x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.46 | 5.46 | 5.25 | 0.92 | 0.84 | 0.42 |
| Quick Ratio | 5.46 | 5.46 | 5.25 | 0.89 | 0.84 | 0.42 |
| Cash Ratio | 3.90 | 3.90 | 3.60 | 0.00 | 0.22 | 0.42 |
| Asset Turnover | — | 2.17 | 1.12 | 2.42 | 2.63 | — |
| Inventory Turnover | 96.51 | — | — | 96.51 | — | — |
| Days Sales Outstanding | — | 31.13 | 78.38 | 87.47 | 73.04 | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Syra Health Corp. Class A Common Stock does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $7M | $5M | $7M | $7M | $6M |
Compare SYRA with 6 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| SYRAYou | $60000 | -0.2 | — | — | 20.7% | -47.2% | -109.1% | -294.7% | — |
| SOLV | $13B | 8.4 | 7.8 | — | 53.5% | 26.2% | 38.9% | 16.9% | 2.3 |
| HCSG | $2B | 26.9 | 24.0 | 12.0 | 13.0% | 2.6% | 10.6% | 7.7% | 0.3 |
| AMN | $987M | -5.1 | 29.2 | 4.1 | 30.8% | -3.4% | -19.1% | -3.9% | 15.4 |
| CCRN | $281M | -19.8 | 319.8 | 2.5 | 20.4% | -1.3% | -3.3% | -3.2% | 6.1 |
| CCEL | $27M | 67.4 | 10.0 | 7.5 | 75.2% | 10.9% | — | — | 3.3 |
| AMS | $14M | 6.4 | 7.7 | — | 32.4% | -9.9% | 7.8% | -5.8% | 6.9 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 5 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SYRA stacks up against sector leader Solventum Corporation.
Start ComparisonSyra Health Corp. Class A Common Stock's current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Syra Health Corp. Class A Common Stock's return on equity (ROE) is -109.1%. The historical average is -116.8%.
Based on historical data, Syra Health Corp. Class A Common Stock is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Syra Health Corp. Class A Common Stock has 20.7% gross margin and -47.2% operating margin.